Spark Addiction, Sell Treatment: Sacklers Sought to Double Dip

As Purdue Pharma raked in profits from its headline painkiller OxyContin, the firm also explored another business opportunity: the “attractive market” of opioid addiction treatment, according to previously secret internal correspondence.
The documents are part of a Massachusetts lawsuit alleging that the Sackler family firm sparked the opioid epidemic. The family has received more than $4 billion from Purdue since 2007.

A laundry list of allegations detail Purdue top brass taking extreme measures to push sales and skirt regulations.
The suit also details how consultants advised the firm on countering “emotional messages” of mothers who’d lost their children to overdose.
ProPublica / STAT


Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top